The BLTT (Bonn Leistungs Tracking Test) in Patients with Temporal Lobe Gliomas—Feasibility of a Novel Neurocognitive Test Battery
NeuroSci · 19.08.2026 · 7 (4) · 91
DOI: 10.3390/neurosci7040091 ↗Kurz gefasst
Fachartikel in der Zeitschrift NeuroSci, online erschienen am 19.08.2026. Verfasst von Sarah-Marie Gallert und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinic and Polyclinic for Neurosurgery, University Hospital Bonn, University of Bonn, 53127 Bonn, Germany. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Neurocognitive testing in neuro-oncological patients often relies on time-intensive batteries with limited feasibility in this patient cohort. We evaluated the feasibility of the Bonn Leistungs Tracking Test (BLTT), a time-efficient screening tool assessing episodic memory, semantic memory, and executive functions in patients with high-grade temporal lobe gliomas.
Methods
Twenty patients undergoing resection of temporal high-grade glioma between 2019 and 2022 underwent preoperative cognitive assessment using either the BLTT or a comprehensive neuropsychological battery routinely applied in temporal lobe epilepsy surgery.
Results
Twelve patients (60%) underwent the BLTT, and eight (40%) underwent the standard neuropsychological test battery. The BLTT was feasible in all 12 individuals (0% drop-out), whereas only four of eight patients (50% drop-out) were able to complete the standard battery. The mean BLTT total score was 69.3 (SD 4.5), indicating impaired neurocognitive performance relative to normative data. The BLTT provided evaluable domain-specific measures across episodic memory, semantic memory, and executive functioning despite the high discontinuation rate observed with standard testing.
Conclusions
The BLTT showed high feasibility for preoperative neurocognitive testing in patients with temporal high-grade gliomas. Its brief administration time and consistent applicability across relevant cognitive domains support its utility for routine neurocognitive assessment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic and Polyclinic for Neurosurgery, University Hospital Bonn, University of Bonn, 53127 Bonn, Germany.
- Tumor Translational Research Group, University Hospital Bonn, University of Bonn, 53127 Bonn, Germany.
- Clinic and Polyclinic for Epileptology, University Hospital Bonn, University of Bonn, 53127 Bonn, Germany.
- Clinic for Neuro-Oncology, Center for Neurology and Integrated Oncology (CIO), University Hospital Bonn, University of Bonn, 53127 Bonn, Germany.
ORCID-Profile: Sarah-Marie Gallert, Julia Taube, Anna-Laura Potthoff, Thomas Zeyen, Valeri Borger, Motaz Hamed, Rainer Surges, Matthias Schneider
Zitieren
APA
Gallert, S. M., Taube, J., Potthoff, A. L., Zeyen, T., Borger, V., Hamed, M., Surges, R., Vatter, H., Helmstaedter, C., & Schneider, M. (2026). The BLTT (Bonn Leistungs Tracking Test) in Patients with Temporal Lobe Gliomas—Feasibility of a Novel Neurocognitive Test Battery. NeuroSci, 7(4), 91. https://doi.org/10.3390/neurosci7040091
Vancouver
Gallert SM, Taube J, Potthoff AL, Zeyen T, Borger V, Hamed M, et al. The BLTT (Bonn Leistungs Tracking Test) in Patients with Temporal Lobe Gliomas—Feasibility of a Novel Neurocognitive Test Battery. NeuroSci. 2026;7(4):91. doi:10.3390/neurosci7040091
BibTeX
@article{Gallert2026,
author = {Gallert, Sarah-Marie and Taube, Julia and Potthoff, Anna-Laura and Zeyen, Thomas and Borger, Valeri and Hamed, Motaz and Surges, Rainer and Vatter, Hartmut and Helmstaedter, Christoph and Schneider, Matthias},
title = {The BLTT (Bonn Leistungs Tracking Test) in Patients with Temporal Lobe Gliomas—Feasibility of a Novel Neurocognitive Test Battery},
journal = {NeuroSci},
year = {2026},
volume = {7},
number = {4},
pages = {91},
doi = {10.3390/neurosci7040091}
}
EUVIMED